BioCentury
ARTICLE | Clinical News

Apogee Biotechnology, RedHill preclinical data

September 7, 2015 7:00 AM UTC

In a xenograft model of prostate cancer, oral ABC294640 significantly inhibited tumor growth. Data were published in Molecular Cancer Research. RedHill is evaluating the small molecule inhibitor of s...